CBU
CYTK icon

CIBC Bancorp USA’s Cytokinetics CYTK Stock Holding History

CIBC Bancorp USA’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$976K Buy
11,461
+1,362
+13% +$97.8K ﹤0.01% 1107
2026
Q1 		$666K Buy
+10,099
New +$642K ﹤0.01% 1145
2025
Q3 		$684K Buy
+12,453
New +$513K ﹤0.01% 761

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Bancorp USA's CYTK Position: Q2 2026 in Review

CIBC Bancorp USA increased its Cytokinetics (CYTK) stake by 13% in Q2 2026, buying an estimated $97.8K and bringing the position to 11,461 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

CIBC Bancorp USA first reported a position in CYTK in Q3 2025 and has held it in 3 quarters since. 447 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • CIBC Bancorp USA held 11,461 shares of Cytokinetics worth $976K as of Q2 2026.
  • CIBC Bancorp USA bought 1,362 Cytokinetics shares in Q2 2026, an estimated $97.8K.
  • Cytokinetics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1107 holding.
  • CIBC Bancorp USA first reported a position in Cytokinetics in Q3 2025 and has held it in 3 quarters since.
  • 447 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.